Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
批准号:
311940-2006
负责人:
Burt, Helen
金额:
$2.51万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31
中文摘要
两亲分子,如二嵌段共聚物,是具有亲水性和疏水性嵌段的大分子。另一种大分子,称为树突状大分子,是高度分支的大分子,具有明确的大小,能够结合药物分子。这些聚合物都形成纳米级的球形颗粒:自缔合胶束(大分子聚集体)、囊泡(由共聚物分子和内部水核组成的外膜)、树状大分子(单分子胶束)和纳米球(固体核心颗粒)。这些所谓的纳米输送系统都可以装载疏水药物,如紫杉醇,有些还可以装载亲水药物,如顺铂。很少有研究探讨聚合物的性质、形成的纳米颗粒类型与纳米递送系统的性能特征之间的关系,如稳定性、药物释放、与血液成分的相互作用、与粘膜组织表面的相互作用和药代动力学。本研究的目的是比较载药聚合物纳米球、囊泡、胶束和树突状制剂在静脉给药和直接局部滴注膀胱治疗膀胱癌后的递送特性、血液/组织相互作用和肿瘤靶向性。纳米递送系统的表面修饰使其具有黏附性,应将纳米颗粒靶向膀胱肿瘤。研究目标是:1)研究聚合物的结构特征对载药纳米递送系统性能的影响;2)确定影响未经处理和表面修饰纳米递送系统与血液成分和膀胱组织相互作用的因素;3)在动物模型中评估经静脉或膀胱给药的选定配方的循环寿命、全身摄取、药代动力学和功效。
英文摘要
Amphiphilic molecules, such as diblock copolymers, are macromolecules with hydrophilic and hydrophobic blocks. Other macromolecules, called dendrimers, are highly branched macromolecules will a well-defined size, capable of binding drug molecules. These polymers all form nanometre size range, spherical particles: self-associating micelles (macromolecular aggregates), vesicles (an outer membrane composed of copolymer molecules and an inner aqueous core), dendrimers (unimolecular micelles) and nanospheres (solid core particles). These so-called nano-delivery systems can all be loaded with hydrophobic drugs, such as paclitaxel, and some will accommodate hydrophilic drugs, such as cisplatin. Few studies have explored the relationship between the properties of the polymer, the type of nanoparticles formed and the performance characteristics of the nano-delivery system, such as stability, drug release, interaction with blood components, interaction with mucosal tissue surfaces and pharmacokinetics. The goal of the proposed research is to compare the delivery characteristics, blood/tissue interactions and tumor targeting of drug loaded polymeric nanosphere, vesicle, micellar and dendritic formulations following both intravenous administration, and local instillation directly into the bladder for application in the treatment of bladder cancer. Surface modification of nano-delivery systems to confer mucoadhesiveness should target the nanoparticles to bladder tumors. The research objectives are: 1) to investigate the influence of structural features of the polymers on properties and performance characteristics of the drug loaded nano-delivery systems, 2) to determine the factors influencing the interactions of untreated and surface modified nano-delivery systems with blood components and bladder tissue, 3) to evaluate the circulation lifetime, systemic uptake, pharmacokinetics and efficacy of selected formulations administered via IV or into the bladders in animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantum Materials and Future Technology
-
批准号:CFREF-2014-00005
-
项目类别:Canada First Research Excellence Fund
-
资助金额:$962.48万
-
财政年份:2021
-
负责人:Burt, Helen
-
依托单位:
Quantum Materials and Future Technologies
-
批准号:10009000009-2017
-
项目类别:Canada First Research Excellence Fund
-
资助金额:$475.1万
-
财政年份:2017
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2012
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2011
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2010
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2009
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
-
批准号:311940-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.51万
-
财政年份:2008
-
负责人:Burt, Helen
-
依托单位:
Burt Lab/Angiotech Pharmaceuticals partnership
-
批准号:340586-2006
-
项目类别:Synergy Awards
-
资助金额:$1.82万
-
财政年份:2006
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
-
批准号:311940-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:Burt, Helen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
泛素结合酶UBE2S调控GPX4/SLC7A11影响肝癌细胞铁死亡的机制研究
-
批准号:32060159
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:莫之婧
-
依托单位:
m6A识别蛋白YTHDF2促白血病细胞生长的研究
-
批准号:32070793
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:赵昀
-
依托单位:
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
-
批准号:32000555
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐亮
-
依托单位:
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
-
批准号:31900528
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:王真
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位: